Teleflex Incorporated (NYSE:TFX) Director Stephen K. M.D. Klasko sold 5,200 shares of the company’s stock in a transaction dated Monday, May 15th. The stock was sold at an average price of $193.56, for a total value of $1,006,512.00. Following the completion of the sale, the director now directly owns 12,880 shares of the company’s stock, valued at approximately $2,493,052.80. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website.
Teleflex Incorporated (NYSE:TFX) opened at 194.50 on Friday. Teleflex Incorporated has a 1-year low of $136.53 and a 1-year high of $211.22. The company has a 50 day moving average price of $198.01 and a 200 day moving average price of $175.61. The firm has a market cap of $8.75 billion, a PE ratio of 40.37 and a beta of 0.93.
Teleflex (NYSE:TFX) last issued its quarterly earnings results on Thursday, May 4th. The medical technology company reported $1.80 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $1.69 by $0.11. The company had revenue of $487.90 million for the quarter, compared to the consensus estimate of $472.81 million. Teleflex had a return on equity of 15.66% and a net margin of 15.09%. The firm’s revenue was up 14.8% compared to the same quarter last year. During the same period last year, the business posted $1.52 earnings per share. On average, equities research analysts forecast that Teleflex Incorporated will post $8.16 earnings per share for the current year.
The firm also recently declared a quarterly dividend, which will be paid on Thursday, June 15th. Stockholders of record on Monday, May 15th will be given a $0.34 dividend. This represents a $1.36 annualized dividend and a dividend yield of 0.70%. The ex-dividend date is Thursday, May 11th. Teleflex’s dividend payout ratio is currently 23.49%.
Large investors have recently modified their holdings of the stock. Great West Life Assurance Co. Can increased its stake in shares of Teleflex by 1.6% in the third quarter. Great West Life Assurance Co. Can now owns 26,029 shares of the medical technology company’s stock valued at $4,372,000 after buying an additional 422 shares in the last quarter. Rothschild Asset Management Inc. increased its stake in shares of Teleflex by 14.9% in the third quarter. Rothschild Asset Management Inc. now owns 2,884 shares of the medical technology company’s stock valued at $485,000 after buying an additional 373 shares in the last quarter. Capital Fund Management S.A. increased its stake in Teleflex by 2,726.0% in the third quarter. Capital Fund Management S.A. now owns 36,258 shares of the medical technology company’s stock worth $6,093,000 after buying an additional 34,975 shares during the period. Quantbot Technologies LP purchased a new stake in Teleflex during the third quarter worth $2,749,000. Finally, LMR Partners LLP purchased a new stake in Teleflex during the third quarter worth $6,913,000. 93.02% of the stock is currently owned by institutional investors.
Several equities research analysts have recently weighed in on the company. Needham & Company LLC reaffirmed a “buy” rating and issued a $224.00 target price on shares of Teleflex in a research report on Friday, May 5th. Deutsche Bank AG upped their target price on Teleflex from $213.00 to $220.00 and gave the stock a “buy” rating in a research report on Monday, May 8th. Zacks Investment Research raised Teleflex from a “hold” rating to a “buy” rating and set a $217.00 target price for the company in a research report on Tuesday, March 14th. Jefferies Group LLC reaffirmed a “hold” rating on shares of Teleflex in a research report on Monday, March 27th. Finally, Barclays PLC reaffirmed a “buy” rating and issued a $205.00 target price on shares of Teleflex in a research report on Wednesday, March 1st. Two analysts have rated the stock with a hold rating, five have assigned a buy rating and one has given a strong buy rating to the company’s stock. The stock presently has a consensus rating of “Buy” and a consensus price target of $208.00.
Teleflex Incorporated is a provider of medical technology products. The Company designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for diagnostic and therapeutic procedures in critical care and surgical applications. The Company operates through six segments: Vascular North America; Anesthesia North America; Surgical North America; Europe, the Middle East and Africa (EMEA); Asia, and Original Equipment Manufacturer (OEM).
Receive News & Ratings for Teleflex Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex Incorporated and related companies with MarketBeat.com's FREE daily email newsletter.